Pharmacokinetics and Safety of ALA in Acne Vulgaris
NCT04044898
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
ALA 5%
DRUG:
ALA 10%
Sponsor
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.